Caffeic acid-pYEEIE

• Description:

  Caffeic acid-pYEEIE, a non-phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain[1].

• UNSPSC:

  12352209

• Target:

  Src

• Type:

  Peptides

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/Caffeic_acid-pYEEIE.html

• Solubility:

  H2O

• Smiles:

  O=C (O) CC[C@@H] (C (O) =O) NC ([C@H] ([C@@H] (C) CC) NC ([C@H] (CCC (O) =O) NC ([C@H] (CCC (O) =O) NC ([C@H] (CC1=CC=C (OP (O) (O) =O) C=C1) NC (/C=C/C2=CC=C (O) C (O) =C2) =O) =O) =O) =O) =O

• Molecular Formula:

  C39H50N5O19P

• Molecular Weight:

  923.81

• References & Citations:

  [1]See-Hyoung Park, et al. Design and characterization of non-phosphopeptide inhibitors for Src family SH2 domains. Bioorg Med Chem Lett. 2002 Oct 7;12 (19) :2711-4.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  507471-72-9